Published in Onkologie on August 01, 2004
Early outcomes of surgery for oesophageal cancer in a thoracic regional unit. Can we maintain training without compromising results? Eur J Cardiothorac Surg (2012) 1.41
Surgical factors influencing outcomes in patients resected for cancer of the esophagus or gastric cardia. World J Surg (2008) 1.38
Centralization of esophageal cancer surgery: does it improve clinical outcome? Ann Surg Oncol (2009) 1.25
High-volume versus low-volume for esophageal resections for cancer: the essential role of case-mix adjustments based on clinical data. Ann Surg Oncol (2007) 1.15
Preoperative risk analysis--a reliable predictor of postoperative outcome after transthoracic esophagectomy? Langenbecks Arch Surg (2006) 0.78
Temporal trends in liver transplant centre volume in the USA. HPB (Oxford) (2009) 0.75
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res (2000) 3.42
ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. J Clin Oncol (2001) 2.87
The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest (1995) 2.35
Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival. Clin Cancer Res (2001) 2.28
Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J Clin Oncol (1997) 2.19
Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur J Pharmacol (1999) 1.95
Options in the management of esophageal perforation: analysis over a 12-year period. Dis Esophagus (2009) 1.63
[Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation]. Pathologe (2004) 1.53
[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer. J Surg Oncol (2010) 1.49
High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J (1992) 1.48
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst (2000) 1.45
Early adenocarcinoma in Barrett's oesophagus. Br J Surg (1997) 1.42
The resection of the azygos vein--necessary or redundant extension of transthoracic esophagectomy? J Gastrointest Surg (2008) 1.41
Tamm-Horsfall protein-mRNA synthesis is localized to the thick ascending limb of Henle's loop in rat kidney. Histochemistry (1990) 1.34
High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus (2004) 1.33
p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival. Clin Cancer Res (1998) 1.32
Molecular biology of esophageal cancer. Onkologie (2004) 1.28
[Does Charlson-comorbidity index correlate with short-term outcome in patients with gastric cancer?]. Zentralbl Chir (2003) 1.26
Prognostic factors of resected adenocarcinoma of the esophagus. Surgery (1995) 1.24
Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. Clin Cancer Res (2001) 1.23
Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg (1997) 1.23
Residents' perceptions of their role as teachers. J Med Educ (1988) 1.20
Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer (1995) 1.19
Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene (2001) 1.17
Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Cancer Res (2001) 1.16
Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer. Histol Histopathol (2008) 1.08
An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics (1998) 1.06
TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and -2 clinical trials. Pharmacogenomics J (2011) 1.06
A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer. Ann Surg (2010) 1.04
Molecular cloning and functional characterization of a mouse bradykinin B1 receptor gene. Biochem Biophys Res Commun (1996) 1.02
Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer. Br J Cancer (2000) 1.02
Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus. Cancer (1994) 1.01
Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis. Ann Oncol (2008) 1.01
Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. J Clin Oncol (1998) 1.00
[Accidentally swallowed dentures--what is the correct diagnostic and therapeutic management?]. Zentralbl Chir (2008) 0.98
Spatial and temporal memory in 20 to 60 year olds. J Gerontol (1981) 0.97
The modified AFP score: an attempt to make the results of anti-reflux surgery comparable. Br J Surg (1991) 0.96
Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer. Br J Cancer (2004) 0.94
Comparative analysis of four histopathological classification systems to discriminate benign and malignant behaviour in gastrointestinal stromal tumors. Anticancer Res (2008) 0.94
Return of interdigestive motor complex after abdominal surgery. End of postoperative ileus? Dig Dis Sci (1991) 0.94
Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy. Cancer Lett (1997) 0.93
Radiotherapy in elderly patients with inoperable esophageal cancer. Is there a benefit? Strahlenther Onkol (2012) 0.93
Gene and pseudogene of the mouse cation-dependent mannose 6-phosphate receptor. Genomic organization, expression, and chromosomal localization. J Biol Chem (1992) 0.92
Preoperative staging of gastric cancer as precondition for multimodal treatment. World J Surg (1995) 0.92
Foetal hepatocyte transplantation in a vascularized AV-Loop transplantation model in the rat. J Cell Mol Med (2008) 0.91
Prognostic impact of nodal micrometastasis in early esophageal cancer. Eur J Surg Oncol (2012) 0.91
Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. Transplantation (2000) 0.90
Survivin expression in gastric cancer: Association with histomorphological response to neoadjuvant therapy and prognosis. J Surg Oncol (2009) 0.88
[Diagnosis of and therapy for gastric cancer--work-flow]. Zentralbl Chir (2009) 0.87
Monoclonal antibodies to denatured human ACE (CD 143), broad species specificity, reactivity on paraffin sections, and detection of subtle conformational changes in the C-terminal domain of ACE. Tissue Antigens (2003) 0.87
Coincidence of nutritional habits and esophageal cancer in Germany. Onkologie (2001) 0.87
[How safe is high intrathoracic esophagogastrostomy?]. Chirurg (2003) 0.87
Esophageal cancer in Germany is associated with Epstein-Barr-virus but not with papillomaviruses. Med Microbiol Immunol (2002) 0.87
Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer. Br J Cancer (2001) 0.87
Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma. J Surg Res (2001) 0.86
Isoforms of angiotensin I-converting enzyme in the development and differentiation of human testis and epididymis. Andrologia (2003) 0.85
The distribution of angiotensin II AT1 receptor subtype mRNA in the rat brain. Neurosci Lett (1992) 0.85
MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR-192 in prediction of multimodality therapy response. Int J Cancer (2013) 0.85
[Squamous cell cancer of the esophagus. Treatment concept at the surgical clinic of the Munich Technical University]. Chirurg (1992) 0.84
Epitope mapping of mAbs to denatured human testicular ACE (CD143). Tissue Antigens (2008) 0.84
Serosal penetration is an important prognostic factor for gastrointestinal stromal tumors. Oncol Rep (2008) 0.84
Thoracoscopic enucleation of esophageal leiomyomas: a feasible and safe procedure. Endoscopy (2007) 0.84
Prognostic differences between early squamous-cell and adenocarcinoma of the esophagus. Dis Esophagus (1997) 0.84
Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer. J Surg Oncol (2009) 0.83
Differential SPARC mRNA expression in Barrett's oesophagus. Br J Cancer (2003) 0.83
Reflux esophagitis, high-grade neoplasia, and early Barrett's carcinoma-what is the place of the Merendino procedure? Langenbecks Arch Surg (2008) 0.83
Prognostic importance of histomorphologic subclassification for epithelial thymic tumors. Ann Surg Oncol (1997) 0.83
Evaluation of histological regression grading systems in the neoadjuvant therapy of rectal cancer: do they have prognostic impact? Int J Colorectal Dis (2012) 0.83
Health-related quality of life after Ivor Lewis esophagectomy. Langenbecks Arch Surg (2012) 0.83
Histopathologic characteristics of early adenocarcinoma in Barrett's esophagus. Cancer (1991) 0.82
Upregulation of ornithine decarboxylase mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma. J Gastrointest Surg (2001) 0.82
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. Transplantation (2001) 0.82
HIF-1alpha protein expression is associated with the environmental inflammatory reaction in Barrett's metaplasia. Dis Esophagus (2009) 0.82
GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancer. Pharmacogenomics J (2009) 0.82